Marshall Wace North America’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-60,544
Closed -$4.57M 1535
2021
Q1
$4.57M Buy
+60,544
New +$4.44M 0.02% 596
2020
Q4
Sell
-162,297
Closed -$8.76M 1375
2020
Q3
$8.76M Buy
162,297
+140,744
+653% +$7.73M 0.06% 297
2020
Q2
$1.03M Buy
+21,553
New +$952K 0.01% 749
2020
Q1
Sell
-32,209
Closed -$2.02M 1325
2019
Q4
$2.02M Buy
+32,209
New +$1.82M 0.01% 574
2019
Q2
Sell
-2,731
Closed -$139K 1268
2019
Q1
$139K Sell
2,731
-3,364
-55% -$147K ﹤0.01% 1056
2018
Q4
$219K Sell
6,095
-46,164
-88% -$2.15M ﹤0.01% 941
2018
Q3
$3.24M Buy
+52,259
New +$2.98M 0.02% 398
2018
Q1
Sell
-49,336
Closed -$3.37M 1497
2017
Q4
$3.37M Sell
49,336
-88,861
-64% -$5.98M 0.02% 690
2017
Q3
$9.99M Sell
138,197
-15,181
-10% -$1.06M 0.06% 363
2017
Q2
$10.3M Buy
153,378
+138,722
+947% +$9.46M 0.08% 309
2017
Q1
$984K Buy
+14,656
New +$977K 0.01% 706

Other funds holding ENOV

Marshall Wace North America's ENOV Position: Q2 2021 in Review

Marshall Wace North America sold out of Enovis (ENOV) in Q2 2021, closing a stake of 60,544 shares — an estimated $4.57M sold.

Marshall Wace North America first reported a position in ENOV in Q1 2017 and held it in 11 quarters. The position peaked at $10.3M in Q2 2017. 277 funds tracked by Wall St. Rank hold ENOV as of Q2 2021.

  • Marshall Wace North America reported no remaining Enovis position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 60,544 Enovis shares in Q2 2021, an estimated $4.57M.
  • Marshall Wace North America first reported a position in Enovis in Q1 2017 and held it in 11 quarters.
  • Marshall Wace North America's Enovis position peaked at $10.3M in Q2 2017.
  • 277 funds tracked by Wall St. Rank held Enovis as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.